BCM
ME

Bayesian Capital Management’s 23andMe Holding Co ME Stock Holding History

Bayesian Capital Management’s Portfolio ME Stock Details ME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,190
Closed -$40K – 1187
2023
Q4 		$40K Buy
+2,190
New +$37.9K ﹤0.01% 681
2022
Q2 		– Sell
-850
Closed -$65K – 1152
2022
Q1 		$65K Buy
+850
New +$77.6K 0.01% 718

Other funds holding ME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SV
Sapphire Ventures Austin, Texas $99.4M AUM 23.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Bayesian Capital Management's ME Position: Q1 2024 in Review

Bayesian Capital Management sold out of 23andMe Holding Co (ME) in Q1 2024, closing a stake of 2,190 shares — an estimated $40K sold.

Bayesian Capital Management first reported a position in ME in Q1 2022 and held it in 2 quarters. The position peaked at $65K in Q1 2022. 149 funds tracked by Wall St. Rank hold ME as of Q1 2024.

  • Bayesian Capital Management reported no remaining 23andMe Holding Co position as of Q1 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 2,190 23andMe Holding Co shares in Q1 2024, an estimated $40K.
  • Bayesian Capital Management first reported a position in 23andMe Holding Co in Q1 2022 and held it in 2 quarters.
  • Bayesian Capital Management's 23andMe Holding Co position peaked at $65K in Q1 2022.
  • 149 funds tracked by Wall St. Rank held 23andMe Holding Co as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.